Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with decreased risk for basal cell carcinoma

Archives of Dermatological Research

Volumn 305, Issue 4, 2013, Pages 333-339

  Yapijakis, Christos ^a   Koronellos, Nikolas ^a   Spyridonidou, Sofia ^a   Vylliotis, Antonis ^a   Avgoustidis, Dimitris ^a   Goutas, Nikolaos ^a   Vlachodimitropoulos, Dimitris ^a   Vairaktaris, Eleftherios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Angiotensin I converting enzyme; Angiotensin receptors; Basal cell carcinoma; Cancer risk; Insertion deletion polymorphism

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DNA;

ADULT; AGED; ANGIOTENSIN CONVERTING ENZYME GENE; ARTICLE; BASAL CELL CARCINOMA; BINDING AFFINITY; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRANSCRIPTION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR BINDING; RISK REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CASE-CONTROL STUDIES; FEMALE; GENE DELETION; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS; SKIN NEOPLASMS;

EID: 84885021173     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-012-1312-7     Document Type: Article

References (62)

1. Ager EI, Neo J, Christophi C (2008) The renin-angiotensin system and malignancy. Carcinogenesis 29(9):1675-1684
2. Akhtar S, Gavalas NG, Gawkrodger DJ, Watson PF, Weetman AP, Kemp EH (2005) An insertion/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalised vitiligo in an English population. Arch Dermatol Res 297(2):94-98
3. Arnon O, Mamelak AJ, Goldberg LH (2008) Basal cell carcinoma arising in a patient with vitiligo. J Drugs Dermatol 7(11):1075-1076
4. Aroni K, Ioannidis E, Voudouris S, Yapijakis C (2011) Homocysteinemia-associated anetoderma, in a young woman with anorexia nervosa history. Int J Dermatol 50:343-345
5. Benndorf R, Böger RH, Ergün S, Steenpass A, Wieland T (2003) Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Circ Res 93(5):438-447
6. Bosnyak S, Jones ES, Christopoulos A, Aguilar MI, Thomas WG, Widdop RE (2011) Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin Sci 121(7):297-303
7. Carter DM, Lin AN (1993) Basal cell carcinoma. In: Fitzpatrick TM, Eisen AZ, Wolff K (eds) Dermatology in general medicine, 4th edn. McGraw-Hill, New York, pp 840-847
8. Chow L, Rezmann L, Catt KJ, Louis WJ, Frauman AG, Nahmias C, Louis SN (2009) Role of the renin-angiotensin system in prostate cancer. Mol Cell Endocrinol 302(2):219-229
9. Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA, VATTC Trial Group (2008) Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. J Natl Cancer Inst 100(17):1223-1232
10. Chung FM, Yang YH, Chen CH, Lin CC, Shieh TY (2005) Angiotensin- converting enzyme gene insertion/deletion polymorphism is associated with risk of oral precancerous lesion in betel quid chewers. Br J Cancer 93:602-606
11. Cocoş R, Schipor S, Nicolae I, Thomescu C, Raicu F (2012) Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G > C PTGS2 polymorphism and NMSC risk. Arch Dermatol Res 304(5):335-342
12. Crowson AN (2006) Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol 19(Suppl 2):S127-S147
13. Crowson AN, Magro CM, Kadin M, Stranc M (1996) Differential expression of bcl-2 oncogene in human basal cell carcinoma. Hum Pathol 27:355-359
14. Dessinioti C, Antoniou C, Katsambas A, Stratigos AJ (2010) Basal cell carcinoma: what's new under the sun. Photochem Photobiol 86(3):481-491
15. Fernandez LA, Twickler J, Mead A (1985) Neovascularization produced by angiotensin II. J Lab Clin Med 105(2):141-145
16. Fleming I (2006) Signaling by the angiotensin-converting enzyme. Circ Res 98(7):887-896
17. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA (1996) Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 28(1):104-108
18. Freitas-Silva M, Pereira D, Coelho C, Bicho M, Lopes C, Medeiros R (2004) Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Cancer Genet Cytogen 155:42-46
19. Friis S, Sorensen HT, Mellemkjaer L, McLaughlin JK, Nielsen GL, Blot WJ, Olsen JH (2001) Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark. Cancer 92(9):2462-2470
20. Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M (2002) Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 294:441-447
21. Gerstenblith MR, Shi J, Landi MT (2010) Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis. Pigment Cell Melanoma Res 23(5):587-606
22. Goldberg LH (1996) Basal cell carcinoma. Lancet 347:663-667
23. Goldstein AM, Bale SJ, Peck GL, DiGiovanna JJ (1993) Sun exposure and basal cell carcinoma in the nevoid basal cell carcinoma syndrome. J Am Acad Dermatol 29:34-41
24. Goto Y, Ando T, Nishio K, Ishida Y, Kawai S, Goto H, Hamajima N (2005) The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis. Asian Pac J Cancer Prev 6(4):464-467
25. Haiman C, Henderson S, Bretsky P, Kolonel L, Henderson B (2003) Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res 63:6984-6987
26. He C, Qureshi AA, Han J (2010) Polymorphisms in genes involved in oxidative stress and their interactions with lifestyle factors on skin cancer risk. J Dermatol Sci 60(1):54-56
27. Iwasaki JK, Srivastava D, Moy RL, Lin HJ, Kouba DJ (2012) The molecular genetics underlying basal cell carcinoma pathogenesis and links to targeted therapeutics. J Am Acad Dermatol 66(5):167-178
28. Jackson A, Brown K, Langdown J, Luddington R, Baglin T (2000) Effect of the angiotensin-converting enzyme gene deletion polymorphism on the risk of venous thromboembolism. Br J Haematol 111(2):562-564
29. Johnson TM, Tschen J, Ho C, Lowe L, Nelson BR (1994) Unusual basal cell carcinomas. Cutis 54:85-92
30. Kosiniak-Kamysz A, PoÅpiech E, Wojas-Pelc A, Marcińska M, Branicki W (2012) Potential association of single nucleotide polymorphisms in pigmentation genes with the development of basal cell carcinoma. J Dermatol doi: 10.1111/j.1346-8138.2012.01559.x
31. Krüger K, Blume-Peytavi U, Orfanos CE (1999) Basal cell carcinoma possibly originates from the outer root sheath and/or the bulge region of the vellus hair follicle. Arch Dermatol Res 291(5):253-259
32. Lacour JP (2002) Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms. Br J Dermatol 146(Suppl 61):17-19
33. Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, Meredith PA, Murray LS, Reid JL, Robertson JW (1998) Do inhibitors of angiotensin-I converting enzyme protect against risk of cancer? Lancet 352(9123):179-184
34. Medeiros R, Vasconcelos A, Costa S, Pinto D, Lobo F, Morais A, Oliveira J, Lopes C (2004) Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol 202:330-335
35. McKenzie CA, Julier C, Forrester T, McFarlane-Anderson N, Keavney B, Lathrop GM, Ratcliffe PJ, Farrall M (1995) Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci. Am J Hum Genet 57:1426-1435
36. Miller SJ (1991) Biology of basal cell carcinoma (Part I). J Am Acad Dermatol 24:1-13
37. Miller SJ (1991) Biology of basal cell carcinoma (Part II). J Am Acad Dermatol 24:161-175
38. Miller DL, Weinstock MA (1994) Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 30:774-778
39. Moscarelli L, Zanazzi M, Mancini G, Rossi E, Caroti L, Rosso G, Bertoni E, Salvadori M (2010) Keratinocyte cancer prevention with ACE inhibitors, angiotensin receptor blockers or their combination in renal transplant recipients. Clin Nephrol 73(6):439-445
40. Nan H, Xu M, Kraft P, Qureshi AA, Chen C, Guo Q, Hu FB, Curhan G, Amos CI, Wang LE, Lee JE, Wei Q, Hunter DJ, Han J (2011) Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma. Hum Mol Genet 20(18):3718-3724
41. Porrello ER, Pfleger KD, Seeber RM, Qian H, Oro C, Abogadie F, Delbridge LM, Thomas WG (2011) Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profiles. Cell Signal 23(11):1767-1776
42. Rao BK, Freeman RG, Poulos EG, Arbesfeld L, Rendon M (1994) The relationship between basal cell epithelioma and seborrheic keratosis. J Dermatol Surg Oncol 20:761-764
43. Rocken C, Lendeckel U, Dierkes J, Westphal S, Carl-McGrath S, Peters B, Krüger S, Malfertheiner P, Roessner A, Ebert MP (2005) The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin Cancer Res 11(7):2526-2530
44. Rodgers K, Xiong S, Felix J, Roda N, Espinoza T, Maldonado S, Dizerega G (2001) Development of angiotensin (1-7) as an agent to accelerate dermal repair. Wound Repair Regen 9(3):238-247
45. Rustemeyer J, Günther L, Deichert L (2011) A rare association: basal cell carcinoma in a vitiliginous macula. Oral Maxillofac Surg 15(3):175-177
46. Scherer D, Kumar R (2010) Genetics of pigmentation in skin cancer - a review. Mutat Res 705(2):141-153
47. Sipahi I, Chou J, Mishra P, Debanne SM, Simon DI, Fang JC (2011) Meta-analysis of randomized controlled trials on effect of angiotensin- converting enzyme inhibitors on cancer risk. Am J Cardiol 108(2):294-301
48. Small W, Molteni A, Kim YT, Taylor JM, Chen Z, Ward WF (1997) Captopril modulates hormone receptor concentration and inhibits proliferation of human mammary ductal carcinoma cells in culture. Breast Cancer Res Treat 44(3):217-224
49. Steckelings UM, Wollschläger T, Peters J, Henz BM, Hermes B, Artuc M (2004) Human skin: source of and target organ for angiotensin II. Exp Dermatol 13(3):148-154
50. Stroth U, Unger T (1999) The renin angiotensin system and its receptors. J Cardiovasc Pharmacol 33:21-28
51. Takeda H, Katagata Y, Kondo S (2002) Immunohistochemical study of angiotensin receptors in human anagen hair follicles and basal cell carcinoma. Br J Dermatol 147(2):276-280
52. Tanioka M, Takahashi K, Kawabata T, Kosugi S, Murakami K, Miyachi Y, Nishigori C, Iizuka T (2005) Germline mutations of the PTCH gene in Japanese patients with nevoid basal cell carcinoma syndrome. Arch Dermatol Res 296(7):303-308
53. Thomas WG (1999) Regulation of angiotensin II type 1 (AT1) receptor function. Regul Pept 79(1):9-23
54. Tsezou A, Karayannis G, Giannatou E, Papanikolaou V, Triposkiadis F (2008) Association of renin-angiotensin system and natriuretic peptide receptor A gene polymorphisms with hypertension in a Hellenic population. J Renin Angiotensin Aldosterone Syst 9(4):202-207
55. Vairaktaris E, Yapijakis C, Tsigris C, Vassiliou S, Derka S, Nkenke E, Spyridonidou S, Vylliotis A, Vorris E, Ragos V, Neukam FW, Patsouris E (2007) Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. Acta Oncol 46(8):1097-1102
56. van Rossum MM, Wopereis D, Hoyer T, Soerjomataram I, Schalkwijk J, van de Kerkhof PC, Kiemeney LA, Hoogerbrugge N (2009) Incidence of cancer in first-degree relatives of basal cell carcinoma patients. Arch Dermatol Res 301(4):295-299
57. Wilkening S, Hemminki K, Rudnai P, Gurzau E, Koppova K, Kumar R, Försti A (2006) Case-control study in basal cell carcinoma of the skin: single nucleotide polymorphisms in three interleukin promoters pre-analysed in pooled DNA. Br J Dermatol 155(6):1139-1144
58. Wu J, Akaike T, Hayashida K, Miyamoto Y, Nakagawa T, Miyakawa K, Müller-Esterl W, Maeda H (2002) Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. Int J Cancer 98:29-35
59. Yamada T, Horiuchi M, Morishita R, Zhang L, Pratt RE, Dzau VJ (1995) In vivo identification of a negative regulatory element in the mouse rennin gene using direct gene transfer. J Clin Invest 96(3):1230-1237
60. Yoshiji H, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Tsujinoue H, Imazu H, Fukui H (2002) Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells. Int J Oncol 20:1227-1231
61. Zemtsov A (2010) Association between basal, squamous cell carcinomas, dysplastic nevi and myotonic muscular dystrophy indicates an important role of RNA-binding proteins in development of human skin cancer. Arch Dermatol Res 302(3):169-170
62. Zhu X, McKenzie CA, Forrester T, Nickerson DA, Broeckel U, Schunkert H, Doering A, Jacob HJ, Cooper RS, Rieder MJ (2000) Localization of a small genomic region associated with elevated ACE. Am J Hum Genet 67(5):1144-1153